Connect with us

Technology

ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA

Published

on

CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ — ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform. This collaboration leverages NVIDIA Inference  microservices (NIM), including the recently published Llama 3 NIM, along with NVIDIA CUDA-X microservices, and the NVIDIA NeMo platform.

Over the past two years, ConcertAI has assembled the deepest and largest multi-modal oncology data repository in the industry, representing more than 8 million patients. This effort was significantly accelerated in December 2023, when the American Society of Clinical Oncology (ASCO) CancerLinQ program became a ConcertAI initiative under a long-term cooperation agreement with ASCO. In collaboration with molecular diagnostic partners and its radiological imaging business, TeraRecon, ConcertAI has established a research capability that spans genomic, transcriptomic, digital pathology, digital radiology, clinical, and social determinants of health data. This comprehensive data set covers all 50 states, offering the broadest representativeness and generalizability of any clinical data source, and forms the foundation for a range of next-generation AI models and AI-powered services. In January, the company announced its CARA AI platform, which underpins a new class of AI SaaS solutions powered by the company’s multi-modal data solutions and supports healthcare providers, research sites, and life science companies. 

As part of the collaboration, ConcertAI’s efforts to drive leading intelligence and insight in oncology research and treatment will be supported by NVIDIA’s AI expertise and infrastructure. This includes incorporating the Meta Llama 3 NIM, announced at Computex today, to drive key LLM workloads inside ConcertAI’s suite of solutions. The focus of ConcertAI’s work with NVIDIA will be on large-scale clinical data processing, multi-agent models, clinical foundation models, and related solutions that enable domain-specific AI and broad application generative AI to interoperate with unprecedented precision.

Key initiatives under this collaboration include:

High-performance AI models for clinical development solutions: This initiative will leverage NVIDIA NIMs to provide scalable, high-performance AI model deployment with low latency, enhancing flexibility, interoperability, and cost efficiency within the ConcertAI CARA AI platform. The integration will support clinical trial patient matching, protocol automation, and research site co-pilots with real-time analytics and model management for large-scale AI applications.Large-scale processing of multi-modal data: This initiative will harness NVIDIA CUDA-X microservices to accelerate ConcertAI’s large-scale data processing pipelines, significantly enhancing the largest curated oncology data set globally. By leveraging CUDA-X’s advanced computing capabilities, ConcertAI will achieve faster data processing speeds and efficiency, enabling more effective management of its vast oncology data.Development of precision oncology and medical large language models (LLMs): These foundation models, trained on ConcertAI’s industry-leading multi-modal data, will support advanced translational simulations to guide novel, first-in-human studies, clinical trial simulations and design optimizations, clinical decision augmentation support for clinical pathways, and identification of beneficial diagnostic and treatment approaches.

“Life sciences research and precision medicine both involve complex decisions based on many types of data and time points,” said Jeff Elton, PhD, CEO of ConcertAI. “For any single patient, we may have billions of unique data points, and we may be looking across millions of records, making this a domain where AI can enable insights not possible with prior technologies or methodologies. We are thrilled to work with NVIDIA to push the boundaries of what AI can achieve in oncology translational research, clinical development, and care. Our collaboration will bring unprecedented precision and new levels of efficiency to our customers’ development of new medicines, helping accelerate the improvement of outcomes for patients with the greatest unmet medical needs.”

“AI offers incredible potential to transform how medicines are designed and developed, and bringing generative AI tools to improve clinical trials is a groundbreaking and necessary step,” said Kimberly Powell, VP of Healthcare at NVIDIA. “Integrating NVIDIA’s NIM’s into ConcertAI’s SaaS and extensive multi-modal data platform will revolutionize clinical trial design and outcome prediction.”

This collaboration underscores ConcertAI’s commitment to harnessing the power of AI to drive innovation in healthcare and improve patient outcomes worldwide. Initial benefits from the collaboration will be accessible in the CARA AI cloud and solutions in Q3 of 2024.

About ConcertAI

ConcertAI is the leader in Predictive and Generative AI SaaS and Real-world Data research solutions and healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARA™ AI technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2000 health care providers, and medical societies.  CancerLinQ® is an Initiative of ConcertAI, providing oncology providers ASCO aligned automated QOPI quality solutions and SmartLinQ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, Tokyo. For more information, visit us at https://www.concertai.com

Media Contact: Megan Duero, megan@galestrategies.com 

View original content:https://www.prnewswire.com/news-releases/concertai-to-advance-translational-and-clinical-development-solutions-in-collaboration-with-nvidia-302161245.html

SOURCE ConcertAI

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Meet With Culture: Exquisite Craftsmanship of Traditional Chinese Architecture

Published

on

By

BEIJING, Dec. 22, 2024 /PRNewswire/ — The Temple of Agriculture in Beijing played a significant role during the Ming (1368-1644) and Qing (1644-1911) dynasties. Over nearly 600 years, 25 emperors personally visited or sent ministers to perform spring farming ceremonies and offer sacrifices to Shennong, the god of agriculture.

 

Built in 1420 during the Yongle reign, the temple’s predecessor was the Temple of Mountains and Rivers in Nanjing. When Emperor Zhu Di moved the Ming capital to Beijing, he constructed a larger temple inspired by the Nanjing temple, which gradually evolved into the Temple of Agriculture.

The Taisui Hall, the largest building complex in the temple, now serves as a major exhibition hall of the Beijing Ancient Architecture Museum, showcasing models of classical Chinese buildings and demonstrating the solemnity of royal architecture.

Ancient Chinese architecture is predominantly wooden-structured, chosen for its availability, versatility, and earthquake resistance. Artisans developed sophisticated techniques in material selection and construction. The wooden framework consists of columns, beams, girders, and purlins, with innovative structural forms like lifting-beam and piercing-bracket structures.

A unique architectural element is the dougong (bracket sets), which supports weight and connects beam frames with column walls. Mortise-tenon joints were invented to create elastic frameworks by connecting different components.

While discussing the Temple of Agriculture, it’s worth noting another remarkable example of architectural hierarchy which could be found in the Temple of Heaven. The hierarchy of architectural designs reflected social stratification, with eave structures like the triple-layered eaves of the Hall of Prayer for Good Harvest representing the highest-level architectural design.

Over centuries, the Temple of Agriculture has transformed from an imperial garden to a public park and a museum for historical architecture, now standing as a significant cultural landmark that symbolizes China’s agricultural civilization and architectural heritage along Beijing’s Central Axis.

Quickly join Alexandre to study and explore the traditional Chinese architecture.
https://youtu.be/YpA03WiZ9Wc

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/meet-with-culture-exquisite-craftsmanship-of-traditional-chinese-architecture-302337935.html

SOURCE China International Communications Group

Continue Reading

Technology

Second Opinion Expert Announces Filing of U.S. Patent for Method of Generating Medical Opinions Using Artificial Intelligence

Published

on

By

Patent leverages AI technology to improve patient outcomes and reduce cost of care

DANA POINT, Calif., Dec. 22, 2024 /PRNewswire-PRWeb/ — SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that it has filed patent application 133902-0002UT01 with the United States Patent and Trademark Office entitled “Method and Apparatus for Generating Automated Medical Opinions Using Artificial Intelligence.” The patent covers the company’s proprietary system that communicates a medical opinion to a user based on a trained model that uses artificial intelligence (AI) or machine learning (ML).

“In the near future, we’ll launch our free app, enabling users to access high-quality medical opinions. This innovative app empowers individuals with insightful medical guidance that improves health and saves lives,” said Steve Krause, President of SecondOpinionExpert, Inc.”

Medical second opinions have traditionally been obtained by seeking out another healthcare professional who reviews the patient’s medical records, diagnoses, and tests. However, the rapidly increasing complexity of medical information, the demand for faster turnaround times, and the limitations of human expert availability have created a need for automated systems that utilize AI to generate both first and second medical opinions.

Artificial intelligence has made significant strides in medical diagnostics, including image recognition, predictive modeling, and natural language processing (NLP). These advancements present an opportunity to augment traditional second opinion systems by automatically processing patient medical records, diagnostic tests, and clinical data to generate high-quality first and second medical opinions.

SecondOpinionExpert’s technology increases the quality and efficiency of healthcare delivery, improves healthcare access and empowers doctors and patients to make better informed medical decisions. The HIPAA-compliant patented platform leverages recent advancements in artificial intelligence, machine learning and electronic medical record systems enabling the company to provide fast, reliable and secure online medical opinions. The system provides patients greater peace of mind by leveraging the power of AI and ML.

“Our patent-pending AI enabled technology platform provides a cost-effective choice that improves patient care,” said Steve Krause, President, SecondOpinionExpert, Inc. “In the near future, we look forward to launching our user-friendly app that will be initially free of charge. People using our platform will be able to quickly obtain high quality medical opinions while avoiding unnecessary travel time and expense, knowing that they will be getting insightful medical guidance that improves health and saves lives.”

About SecondOpinionExpert

SOE’s mission is to provide innovative medical technology solutions to improve healthcare while reducing costs.

Our patented HIPAA-compliant platform leverages recent advancements in artificial intelligence, machine learning and electronic medical record systems, enabling the company to provide fast, reliable and secure online medical opinions to inform both diagnosis and treatment planning. We empower patients, providers and payors to work together to make the best possible medical decisions, leading to better health outcomes and greater peace of mind for patients. SOE’s panel of 400+ board-certified medical specialists are available to render expert opinions informed as needed by AI and genomics.

SOE also owns and/or manages a rapidly growing network of facilities for post-acute care and substance treatment. Our proprietary platform for Electronic Medical Records (EMR) empowers best practices in administration and medical services.

Our proprietary TeleMedics Mobile Platform empowers and chronicles on-site visits from qualified medics or nurses. Mobile staff provide the human connection, capturing vitals and doing diagnostics and therapeutics, with the patient’s doctor participating as needed through live video. We work with our affiliate Intra Care, Inc. to provide superior home health and hospice care. We provide Remote Patient Monitoring (RPM) delivered through a strategic relationship with KangarooHealth, in-home respirators delivered and monitored by SOE affiliate Momentum Equipment and Pandemic Response through our MaxVax solution.

Additional information can be found at SOE.CARE

Media Contact

Jay Kilberg, Second Opinion Expert, Inc., 1 917.543.6285, jay.kilberg@soe.care, https://soe.care

Facebook, LinkedIn

View original content to download multimedia:https://www.prweb.com/releases/second-opinion-expert-announces-filing-of-us-patent-for-method-of-generating-medical-opinions-using-artificial-intelligence-302337240.html

SOURCE Second Opinion Expert, Inc.

Continue Reading

Technology

The 6th “My China Story” International Short Video Competition Award Ceremony Held in Harbin

Published

on

By

HARBIN, China, Dec. 22, 2024 /PRNewswire/ — The 6th “My China Story” International Short Video Competition Award Ceremony was held in Harbin, northeast China’s Heilongjiang Province on December 19, 2024.

Du Zhanyuan, member of the Standing Committee of the 14th National Committee of the Chinese People’s Political Consultative Conference and president of China International Communications Group, and He Liangjun, member of the Standing Committee of the Heilongjiang Provincial Committee of the Communist Party of China (CPC) and director of the Publicity Department of the CPC Heilongjiang Provincial Committee, addressed the ceremony respectively. Lan Feng, member of the Standing Committee of the CPC Harbin Municipal Committee and director of the Publicity Department of the CPC Harbin Municipal Committee, attended the event. The ceremony was also attended by 300 other people from home and abroad, including Chinese and international video creators, experts, judges, and representatives from the publicity departments at different levels across the country, as well as representatives from various corporations.

For this year, the competition received a total of 59,559 videos from more than 130 countries and regions around the globe. After three rounds of strict comparison and appraisal by more than 30 professional Chinese and international judges from the fields of media, film and television, Internet, and international communication, 112 pieces of all videos finally won awards in different categories.

Heilongjiang, the northernmost and easternmost province of China, boasts a long history and rich culture. Harbin, the capital city of Heilongjiang Province, is famous for its local culture, music, art and architecture of Chinese and Western integrated styles as well as its openness and inclusiveness, making the city a unique source of inspiration to tell China stories to the world.

Under the theme of “Heaven of Ice and Snow, City of Charm and Vigor”, this year’s competition highlights the feature of the host city Harbin, attracting a lot of participants to make videos surrounding the topic. From the perspective of international creators, these short videos together present a dynamic Harbin and a charming Heilongjiang, as well as show a real China to the world.

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-6th-my-china-story-international-short-video-competition-award-ceremony-held-in-harbin-302337936.html

SOURCE “My China Story” International Short Video Competition Organizing Committee

Continue Reading

Trending